Publications by authors named "Peter Boer"

Claim this Profile
D
Differences in resting state and task-based EEG measures between patients with major depressive disorder and healthy controls.
Natasha Kovacevic, Amir Meghdadi, Chris Berka, Ziad S Saad, Hartmuth C Kolb, Peter de Boer

Clin Neurophysiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.
Kasper Recourt, Peter de Boer, Peter van der Ark, Heike Benes, Joop M A van Gerven

Transl Psychiatry· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling classical neuropsychiatric biomarkers across biological fluids and following continuous lumbar puncture: A guide to sample type and time.
Gallen Triana-Baltzer, Maarten Timmers, Peter De Boer, Manja Schoene, Maura Furey

Compr Psychoneuroendocrinol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageing.
John J Cole, Alison McColl, Robin Shaw, Mary-Ellen Lynall, Philip J Cowen, Peter de Boer

Transl Psychiatry· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.
Livia De Picker, Erik Fransen, Violette Coppens, Maarten Timmers, Peter de Boer

Front Immunol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning-based reconstruction of in vivo pelvis conductivity with a 3D patch-based convolutional neural network trained on simulated MR data.
Soraya Gavazzi, Cornelis A T van den Berg, Mark H F Savenije, H Petra Kok, Peter de Boer

Magn Reson Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study.
Annamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, Nicole Mariani, Daniela Enache, Peter de Boer

Transl Psychiatry· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Emery, 1898 (Formicidae, Hymenoptera): a cryptic globally introduced species.
Peter Boer, Ana Carolina Loss, Frederique Bakker, Kevin Beentjes, Brian L Fisher

Zookeys· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial.
Kasper Recourt, Jasper van der Aart, Gabriel Jacobs, Marieke de Kam, Wayne Drevets, Peter de Boer

J Psychopharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Cell-Stratified Subgroups of Inflamed Depression.
Mary-Ellen Lynall, Lorinda Turner, Junaid Bhatti, Jonathan Cavanagh, Peter de Boer

Biol Psychiatry· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study.
Annamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, Nicole Mariani, Daniela Enache, Peter de Boer

Transl Psychiatry· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder.
Seline van den Ameele, Alexander Ln van Nuijs, Foon Yin Lai, Jeroen Schuermans, Robert Verkerk, Peter de Boer

Bipolar Disord· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine effects on default mode network activity and vigilance: A randomized, placebo-controlled crossover simultaneous fMRI/EEG study.
Norman Zacharias, Francesco Musso, Felix Müller, Florian Lammers, Andreas Saleh, Peter de Boer

Hum Brain Mapp· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine and Inflammatory Effects of Childhood Trauma Following Psychosocial and Inflammatory Stress in Women with Remitted Major Depressive Disorder.
Laura L M Cassiers, Peter Niemegeers, Erik Fransen, Manuel Morrens, Peter De Boer

Brain Sci· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Kasper Recourt, Peter de Boer, Rob Zuiker, Remy Luthringer, Justine Kent

Transl Psychiatry· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective validation of craniocaudal tumour size on MR imaging compared to histoPAthology in patients with uterine cervical cancer: The MPAC study.
Peter de Boer, Anje M Spijkerboer, Maaike C G Bleeker, Luc R C W van Lonkhuijzen, Mélanie A Monraats

Clin Transl Radiat Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Kasper Recourt, Peter de Boer, Rob Zuiker, Remy Luthringer, Justine Kent

Transl Psychiatry· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies of Laboulbeniales on Myrmica ants (IV): host-related diversity and thallus distribution patterns of Rickia wasmannii.
Danny Haelewaters, Peter Boer, Ferenc Báthori, Zoltán Rádai, Ana Sofia P S Reboleira

Parasite· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State-associated changes in longitudinal [F]-PBR111 TSPO PET imaging of psychosis patients: Evidence for the accelerated ageing hypothesis?
Livia De Picker, Julie Ottoy, Jeroen Verhaeghe, Steven Deleye, Leonie Wyffels, Peter de Boer

Brain Behav Immun· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digging deeper in the differential effects of inflammatory and psychosocial stressors in remitted depression: Effects on cognitive functioning.
Peter Niemegeers, Peter de Boer, Jeroen Schuermans, Glenn J H Dumont, Violette Coppens

J Affect Disord· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.
Sander Brooks, Gabriël E Jacobs, Peter de Boer, Justine M Kent, Luc Van Nueten

J Psychopharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network.
Felix Mueller, Francesco Musso, Markus London, Peter de Boer, Norman Zacharias

Neuroimage Clin· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical cancer apparent diffusion coefficient values during external beam radiotherapy.
Peter de Boer, Stefano Mandija, Anita M Werensteijn-Honingh, Cornelis A T van den Berg, Astrid A C de Leeuw

Phys Imaging Radiat Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects.
Peter D van der Ark, Georg Golor, Luc van Nueten, Partha Nandy, Peter de Boer

J Psychopharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants.
Maarten Timmers, Paulien Ravenstijn, Liwen Xi, Gallen Triana-Baltzer, Maura Furey, Maarten van den Boer, Peter de Boer

J Psychopharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis